*Any patient showing a positive skin smear, irrespective of the clinical classification, should be treated with the multibacillary (MB) regimen. However, this depends on the availability of reliable laboratory facilities. Furthermore, the increasing prevalence of the HIV and hepatitis B infection in many leprosy-endemic countries points to the need to limit both the number of skin sites and the frequency of smear collection to a minimum (see references).
